Free Trial

Quanterix (QTRX) Competitors

Quanterix logo
$5.36 -0.24 (-4.29%)
Closing price 04:00 PM Eastern
Extended Trading
$5.36 0.00 (0.00%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

QTRX vs. TRNS, CTKB, LAB, SENS, ALNT, EYPT, AEHR, QSI, FEIM, and MASS

Should you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Quantum-Si (QSI), Frequency Electronics (FEIM), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

Quanterix vs.

Transcat (NASDAQ:TRNS) and Quanterix (NASDAQ:QTRX) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, community ranking, media sentiment, dividends, profitability and analyst recommendations.

Transcat has a net margin of 6.22% compared to Quanterix's net margin of -30.12%. Transcat's return on equity of 7.23% beat Quanterix's return on equity.

Company Net Margins Return on Equity Return on Assets
Transcat6.22% 7.23% 5.67%
Quanterix -30.12%-11.74%-9.66%

98.3% of Transcat shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 6.9% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Transcat has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Transcat$272.20M2.95$13.65M$1.8546.64
Quanterix$135.44M1.54-$28.35M-$1.03-5.20

Transcat currently has a consensus price target of $111.50, suggesting a potential upside of 29.23%. Quanterix has a consensus price target of $18.25, suggesting a potential upside of 240.49%. Given Quanterix's stronger consensus rating and higher possible upside, analysts clearly believe Quanterix is more favorable than Transcat.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Transcat
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Quanterix
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Quanterix received 61 more outperform votes than Transcat when rated by MarketBeat users. However, 66.14% of users gave Transcat an outperform vote while only 61.82% of users gave Quanterix an outperform vote.

CompanyUnderperformOutperform
TranscatOutperform Votes
211
66.14%
Underperform Votes
108
33.86%
QuanterixOutperform Votes
272
61.82%
Underperform Votes
168
38.18%

In the previous week, Transcat had 1 more articles in the media than Quanterix. MarketBeat recorded 6 mentions for Transcat and 5 mentions for Quanterix. Transcat's average media sentiment score of 1.71 beat Quanterix's score of 1.01 indicating that Transcat is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Transcat
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Quanterix
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Transcat has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.

Summary

Transcat beats Quanterix on 12 of the 18 factors compared between the two stocks.

Remove Ads
Get Quanterix News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTRX vs. The Competition

MetricQuanterixAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$207.91M$4.09B$5.33B$7.57B
Dividend YieldN/A0.60%5.11%4.32%
P/E Ratio-5.0626.9021.7317.81
Price / Sales1.544.17379.2094.61
Price / CashN/A36.0838.1534.64
Price / Book0.581.696.464.00
Net Income-$28.35M-$83.57M$3.20B$247.23M
7 Day Performance10.29%10.21%6.54%7.26%
1 Month Performance-24.08%-6.67%-8.55%-6.26%
1 Year Performance-68.75%-35.15%10.33%-0.18%

Quanterix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTRX
Quanterix
2.3265 of 5 stars
$5.36
-4.3%
$18.25
+240.5%
-69.5%$207.91M$135.44M-5.06460Short Interest ↑
Positive News
TRNS
Transcat
2.6571 of 5 stars
$77.70
+3.3%
$111.50
+43.5%
-24.5%$723.31M$272.20M42.00920News Coverage
Positive News
Gap Down
High Trading Volume
CTKB
Cytek Biosciences
1.8264 of 5 stars
$3.67
-1.1%
$6.42
+74.8%
-39.1%$470.12M$200.45M-45.87500Short Interest ↑
Gap Down
LAB
Standard BioTools
2.7479 of 5 stars
$1.10
+2.8%
$2.50
+127.3%
-58.8%$416.89M$174.43M-1.55620Gap Down
SENS
Senseonics
1.7041 of 5 stars
$0.56
-3.0%
$2.00
+260.1%
+28.0%$362.04M$22.47M-4.2790
ALNT
Allient
4.4042 of 5 stars
$20.45
+0.4%
$31.00
+51.6%
-33.0%$346.59M$529.97M23.241,950Positive News
EYPT
EyePoint Pharmaceuticals
1.5095 of 5 stars
$4.62
+0.2%
$26.63
+476.3%
-74.6%$317.53M$43.27M-2.31120Positive News
AEHR
Aehr Test Systems
3.8022 of 5 stars
$7.22
-0.6%
$25.00
+246.3%
-29.1%$214.52M$50.74M9.6390Analyst Revision
QSI
Quantum-Si
1.9773 of 5 stars
$1.14
+0.9%
$3.48
+204.8%
-27.2%$208.78M$3.06M-1.78150Short Interest ↑
FEIM
Frequency Electronics
1.8458 of 5 stars
$15.08
+0.1%
N/A+75.6%$145.93M$65.40M18.39200Short Interest ↑
MASS
908 Devices
2.7157 of 5 stars
$3.81
flat
$5.33
+40.0%
-27.2%$134.61M$59.63M-2.1560News Coverage
Remove Ads

Related Companies and Tools


This page (NASDAQ:QTRX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners